The Monkeypox vaccine has just been given the green light by the Federal Drug Administration (FDA) to be administered via intradermal injection. This method will allow healthcare professionals to get ...

First human DNA vaccine First in class thermostable self-amplifying mRNA vaccine GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company engineering precision delivery systems that overcome challenges ...

Intradermal administration of the JYNNEOS mpox vaccine is as effective and safe as subcutaneous administration, according to new data released this week by the Centers for Disease Control and ...

A less common injection method allows a single dose to be split into five Warning: This graphic requires JavaScript. Please enable JavaScript for the best experience ...

97% of healthcare workers preferred Tropis® ID for routine immunization. Vaccinators noted Tropis is easy to operate, resulted in less perceived child discomfort, and elicits a positive caregiver ...

PharmaTher Holdings PHRRF, the biopharma company developing novel uses and delivery forms of ketamine for mental health treatments, has completed an IND-enabling pharmacokinetic and tolerability study ...

PharmaJet presentation will highlight the results of recent immunization studies using needle-free intradermal (ID) delivery for polio immunization campaigns. Data reinforces how increased coverage, ...

PharmaJet® to Highlight the Benefits of Intradermal Needle-free Delivery and Expansion into the Self-Injection Pen Market at Upcoming PODD Conference PharmaJet will deliver two presentations on ...

NanoPass Technologies Ltd., a global leader in intradermal delivery solutions, will officially launch MicronJet™ 800 during IMCAS World 2026, taking place January 29 – 31, 2026, in Paris.